Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection

被引:156
|
作者
Thorburn, K. [1 ]
机构
[1] Royal Liverpool Childrens Hosp, Dept Paediat Intens Care, Liverpool L12 2AP, Merseyside, England
关键词
VIRAL-INFECTION; US CHILDREN; MORTALITY; BRONCHIOLITIS; INFANTS; INFLUENZA;
D O I
10.1136/adc.2008.139188
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Background: 600 000 deaths worldwide are estimated to be directly or indirectly attributable to respiratory syncytial virus (RSV). Objectives: To determine: ( 1) the mortality rate; and ( 2) risk factors for death in children with severe RSV infection. Setting: 20-bed, regional, multidisciplinary, tertiary, paediatric intensive care unit (PICU) in a university-affiliated children's hospital. Methods: Cohort study of all children with severe RSV infection covering eight consecutive RSV seasons (1999-2007), using PICU admission as a marker of severity. Results: Of the 406 RSV-positive patients that were admitted to PICU: 98.5% required mechanical ventilation; 35 children died-median age 5.1 months (interquartile range (IQR) 2.4-13.6), length of PICU stay 16 days ( IQR 8-31) and 371 survived-median age 2.5 months ( IQR 1.2-9), length of PICU stay 5 days ( IQR 4-9). The overall PICU RSV mortality was 8.6% with a standardised mortality ratio of 0.76. During the study period 2009 RSV-positive patients were admitted to the children's hospital, giving a hospital RSV mortality rate of 1.7%. Of the deaths, 18 were directly RSV related ( RSV bronchiolitis-related mortality PICU 4.4% and hospital 0.9%) as the patients were still RSV positive when they died and 17 children died from non-pneumonitis causes after becoming RSV negative. All of the RSV deaths had pre-existing medical conditions -chromosomal abnormalities 29%, cardiac lesions 27%, neuromuscular 15%, chronic lung disease 12%, large airway abnormality 9%, and immunodeficiency 9%. Nineteen children (56%) had pre-existing disease in two or more organ systems ( relative risk (RR) 4.38). Predisposing risk factors for death were pre-existing disease ( RR 2.36), cardiac anomaly ( RR 2.98) and nosocomial/hospital-acquired RSV infection ( RR 2.89). There is an interaction effect between pre-existing disease, nosocomial/hospital-acquired RSV infection and mortality ( p < 0.001). Conclusions: Pre-existing disease/comorbidity, in particular multiple pre-existing diseases and cardiac anomaly, is associated with a significantly higher risk of death from severe RSV infection. Nosocomial/hospital-acquired RSV infection is an additional major risk factor for death in children with severe RSV infection.
引用
收藏
页码:99 / 103
页数:5
相关论文
共 50 条
  • [1] Risk factors associated with death in patients with severe respiratory syncytial virus infection
    Lee, Yen-I
    Peng, Chun-Chih
    Chiu, Nan-Chang
    Huang, Daniel Tsung-Ning
    Huang, Fu-Yuan
    Chi, Hsin
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (05) : 737 - 742
  • [2] Morbidity and outcome of severe respiratory syncytial virus infection
    El Kholy, Amani A.
    Mostafa, Nadia A.
    El-Sherbini, Seham A.
    Ali, Aliaa A.
    Ismail, Reem I.
    Magdy, Rania I.
    Hamdy, Mona S.
    Soliman, May S.
    PEDIATRICS INTERNATIONAL, 2013, 55 (03) : 283 - 288
  • [3] Severe Respiratory Syncytial Virus Infection in Hospitalized Children
    Gonzalez-Ortiz, Ana M.
    Bernal-Silva, Sofia
    Comas-Garcia, Andreu
    Vega-Morua, Maria
    Garrocho-Rangel, Maria E.
    Noyola, Daniel E.
    ARCHIVES OF MEDICAL RESEARCH, 2019, 50 (06) : 377 - 383
  • [4] Defining the Risk and Associated Morbidity and Mortality of Severe Respiratory Syncytial Virus Infection Among Infants with Congenital Heart Disease
    Checchia, Paul A.
    Paes, Bosco
    Bont, Louis
    Manzoni, Paolo
    Simeos, Eric A. F.
    Fauroux, Brigitte
    Figueras-Aloy, Josep
    Carbonell-Estrany, Xavier
    INFECTIOUS DISEASES AND THERAPY, 2017, 6 (01) : 37 - 56
  • [5] Risk factors for hospitalized respiratory syncytial virus disease and its severe outcomes
    Cai, Wei
    Buda, Silke
    Schuler, Ekkehard
    Hirve, Siddhivinayak
    Zhang, Wenqing
    Haas, Walter
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2020, 14 (06) : 658 - 670
  • [6] Laboratory Confirmation of Respiratory Syncytial Virus Infection Is Not Associated With an Increased Risk of Death in Adults With Acute Respiratory Illness
    Kline, Jeffrey A.
    Welch, Robert D.
    Kabrhel, Christopher
    Courtney, Daniel Mark
    Camargo Jr, Carlos A.
    OPEN FORUM INFECTIOUS DISEASES, 2025, 12 (02):
  • [7] Risk Factors for Severe Respiratory Syncytial Virus Infection in Hospitalized Children
    Kobialka, Malgorzata
    Jackowska, Teresa
    Wrotek, August
    VIRUSES-BASEL, 2023, 15 (08):
  • [8] Novel Inflammatory Markers, Clinical Risk Factors and Virus Type Associated With Severe Respiratory Syncytial Virus Infection
    Tabarani, Christy M.
    Bonville, Cynthia A.
    Suryadevara, Manika
    Branigan, Patrick
    Wang, Dongliang
    Huang, Danning
    Rosenberg, Helene F.
    Domachowske, Joseph B.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2013, 32 (12) : E437 - E442
  • [9] Risk factors for severe respiratory syncytial virus infection in infants
    Aujard, Y
    Fauroux, B
    RESPIRATORY MEDICINE, 2002, 96 : S9 - S14
  • [10] Risk of mortality associated with respiratory syncytial virus and influenza infection in adults
    Kwon, Yong Shik
    Park, Sun Hyo
    Kim, Mi-Ae
    Kim, Hyun Jung
    Park, Jae Seok
    Lee, Mi Young
    Lee, Choong Won
    Dauti, Sonila
    Choi, Won-Il
    BMC INFECTIOUS DISEASES, 2017, 17